International - The Aurum Institute

Why there is great enthusiasm for AI in the global south

...
Antibiotic slashes risk of drug-resistant TB in kids, major SA study finds

...
Pepfar head assures countries of its continued support for HIV/Aids fight

...
New Child-friendly TB Prevention Treatment Available

...
Kenyan children at risk of TB to get sweet prevention drugs

...
World TB Day 2024: Aurum Institute Ghana commits to ending TB in Ghana

The commitment of The Aurum Institute Ghana to combating tuberculosis (TB) remains resolute. In support of World TB Day 2024, Aurum Ghana proudly stood alongside Ghana Health Services to address the ...
Prof Kaleebu receives the honorary title of Officer of the Most Excellent Order of the British Empire

Professor Pontiano Kaleebu, an esteemed Aurum Board Member and the outgoing Director of the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicin...
USAID-Funded ACCELERATE Initiative to Boost Tuberculosis Elimination Efforts in South Africa

In a landmark move towards ending tuberculosis (TB) in South Africa, the U.S. Agency for International Development (USAID) has awarded the Aurum Institute US $47 million (approx. R886 million) to impl...
World TB Day: Fundação Aurum participates in Costa do Sol Health Fair to end TB in Maputo

In celebration of global efforts towards ending TB tuberculosis (TB) on World Tuberculosis Day, Fundação Aurum, alongside the Maputo City Council hosted the Costa do Sol Av. Marginal Health Fair in ...
World Tuberculosis Day: discover a Horizon 2020 project that is contributing to making a change in the field of tuberculosis treatment

...
World TB Day 2024: focus on long-term effects

...
Revolutionising Pediatric TB Prevention: Insights from the Rifapentine Dispersible Formulation Webinar

In a monumental stride towards global tuberculosis (TB) prevention, a powerhouse collaboration of leading organisations recently convened a groundbreaking webinar on the dispersible formulation of rif...
The Aurum Institute Calls for Sustained Investment to Ensure Progress in TB Care

For over two decades, Aurum, as an African-led organisation, has been at the forefront of the TB response, driving research and innovation, and supporting implementation of programmes to improve healt...
How global health institutions and funders can empower local researchers

While many organisations in the global north claim to support locally led development, the reality often falls short due to donor practices and inadequate investment in capacity building. However, eve...
Aurum's Commitment to Healthcare Access and Health Equity in Africa

Lagos, Nigeria, May 9, 2024 - The Aurum Institute participated in the 2024 Industry Engagement Forum, themed “Unlocking Healthcare Value Chains and Driving Investment through Partnerships: Accelerat...
World TB Month: PanTB-HM site tour

Tuberculosis remains a formidable global health challenge, causing significant morbidity and mortality worldwide. Even after successful treatment, many patients experience lasting lung damage, comprom...
How global health institutions and funders can empower local researchers

...
Gilead Announces 100% Efficacy in HIV Prevention for Cisgender Women with Lenacapavir in Aurum conducted trial

The Aurum Institute welcomes the announcement from Gilead on the provisional results of the Phase 3 PURPOSE 1 trial. The trial has demonstrated that Gilead's twice-yearly injectable HIV-1 capsid inhib...
Enhancing collaboration between local and international organizations

...
Aurum's Community Engagement Manager joins Global TB Advisory Board

The Aurum Institute is proud to announce that Blossom Makhubalo, our Community Engagement Manager, has been appointed as one of the newest members of the Global Tuberculosis Community Advisory Board (...